Oncolytic Biotechnology

Oncolytic Biotechnology is that the study of oncolytic virus, the virus that preferentially infects and kills cancer cells. As the infected cancer cells unit destroyed by oncolysis, they undo new infectious virus particles or virions to assist destroy the remaining growth. Oncolytic viruses area unit thought not solely to cause direct destruction of the tumor cells, however conjointly to stimulate host anti-tumour immune responses.

    Related Conference of Oncolytic Biotechnology

    February 25-26, 2026

    6th International Conference on Biomedicine & Pharmacotherapy

    Rome, Italy
    March 23-24, 2026

    29th European Biotechnology Congress

    Rome, Italy
    April 27-28, 2026

    7th Annual Congress on Biosimilars and Future Biotherapeutics

    Paris, France
    April 27-28, 2026

    32nd Asia Pacific Biotechnology Congress

    Dubai, UAE
    June 29-30, 2026

    41st International Conference on Next-Gen Biotechnology and Applications

    Aix-en-Provence, France
    July 23-24, 2026

    27th Global Summit on Analytical and Bioanalytical Techniques

    Paris, France
    August 13-14, 2026

    21st World Congress on Biomarkers, Cancer Therapy & Clinical Research

    San Diego, USA
    August 27-28, 2026

    30th Global Congress on Biotechnology

    Berlin, Germany

    Oncolytic Biotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in